drugset
drugset / Trial / NCT06006689

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

NCT06006689 ↗

Phase 2 Unknown 228 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and Safety of QiShen YiQi Dripping Pills in the treatment of Diabetic Kidney Disease (syndrome of Qi deficiency with blood stasis)

Timeline

Start
2023-09-04
Primary completion
2025-09-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 1.04 g Oral
Subject Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 1.56 g Oral

Indications

diabetic kidney disease